Ropinirole Alternatives Compared
| Ropinirole | Ingrezza | Austedo |
|
|---|
| Ropinirole | Ingrezza (valbenazine) | Austedo (deutetrabenazine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ropinirole is used in the treatment of restless legs syndrome and Parkinson's disease; however, it may cause drowsiness which has caused some people to fall asleep while driving - do not drive if... View more |
Prescription only
Ingrezza may be used to treat adults with tardive dyskinesia or chorea associated with Huntington's disease. It works by blocking VMAT2, which reduces the uptake of dopamine by the brain. Although... View more |
Prescription only
Austedo may be used to treat Huntington’s chorea or tardive dyskinesia and works by blocking the action of VMAT2 which is a protein that controls the transfer of chemical messengers between nerves i... View more |
Related suggestions Tardive Dyskinesia
Popular comparisons
|
|||||||||||||||||||||||
| More about Ropinirole | More about Ingrezza (valbenazine) | More about Austedo (deutetrabenazine) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Ropinirole has an average rating of 6.4 out of 10 from a total of 322 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 27% reported a negative effect. |
Ingrezza has an average rating of 4.7 out of 10 from a total of 13 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 54% reported a negative effect. |
Austedo has an average rating of 5.8 out of 10 from a total of 8 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Commonly reported side effects include:
See also: ropinirole side effects in more detail. |
Common side effects include:
See also: Ingrezza side effects in more detail. |
Common side effects include:
See also: Austedo side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all ropinirole prices |
View all Ingrezza prices |
View all Austedo prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Other deutetrabenazine brands include: Austedo XR | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
6 hours |
22 hours |
10 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 299 drugs are known to interact with ropinirole:
|
A total of 487 drugs are known to interact with Ingrezza:
|
A total of 434 drugs are known to interact with Austedo:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 19, 1997 |
April 11, 2017 |
April 03, 2017 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.